cefixime and ly 163892

cefixime has been researched along with ly 163892 in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (78.57)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M1
Brumfitt, W; Hamilton-Miller, JM1
Anderson, RL; McKnight, JT; Rodman, DP1
Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R1
Rodriguez, WJ; Wiedermann, BL1
Dantzig, AH; Duckworth, DC; Tabas, LB1
Bass, JW; Chan, DS; Demers, DM1
Berman, S; Roark, R1
Cappelletty, DM; Rybak, MJ1
Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA1
Clauss, W; Daniel, H; Gebert, I; Weber, WM; Weintraut, H; Wenzel, U1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

4 review(s) available for cefixime and ly 163892

ArticleYear
A critical review of the new oral cephalosporins. Considerations and place in therapy.
    Archives of family medicine, 1994, Volume: 3, Issue:11

    Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Humans

1994
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
    Advances in pediatric infectious diseases, 1994, Volume: 9

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans

1994
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:3

    Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic

1996
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for cefixime and ly 163892

ArticleYear
Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef.
    The Pediatric infectious disease journal, 1994, Volume: 13, Issue:2

    Topics: Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Single-Blind Method; Smell; Suspensions; Taste

1994
Factors influencing outcome in children treated with antibiotics for acute otitis media.
    The Pediatric infectious disease journal, 1993, Volume: 12, Issue:1

    Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome

1993

Other Studies

8 other study(ies) available for cefixime and ly 163892

ArticleYear
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:8

    Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis

1992
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Drugs under experimental and clinical research, 1991, Volume: 17, Issue:10-11

    Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Urinary Tract Infections

1991
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:6

    Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control

1994
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
    Biochimica et biophysica acta, 1994, Apr-20, Volume: 1191, Issue:1

    Topics: Adenocarcinoma; Amino Acids; Biological Transport; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Colonic Neoplasms; Dipeptides; Drug Antagonism; Energy Metabolism; Humans; Intestinal Absorption; Tumor Cells, Cultured

1994
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5

    Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae

1996
Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2

    Topics: Animals; Biological Transport; Caco-2 Cells; Carrier Proteins; Cephalosporins; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Oocytes; Peptide Transporter 1; Rabbits; Symporters; Xenopus laevis

1996
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008